## **Core Concept**
The question tests knowledge of beta-lactam antibiotics, specifically their effectiveness against *Pseudomonas aeruginosa*, a type of bacteria known for causing infections, particularly in immunocompromised individuals. Beta-lactam antibiotics work by inhibiting bacterial cell wall synthesis. *Pseudomonas aeruginosa* is notorious for its intrinsic resistance to many antibiotics.

## **Why the Correct Answer is Right**
Option is the correct answer because among the given choices, it does not possess significant antipseudomonal activity. This requires understanding the spectrum of activity of various beta-lactam antibiotics. For instance, **piperacillin** (a broad-spectrum penicillin) and **ceftazidime** (a third-generation cephalosporin) are known for their antipseudomonal properties. **Meropenem**, a carbapenem, also has a broad spectrum of activity that includes *Pseudomonas*. However, not all beta-lactams are effective against *Pseudomonas*.

## **Why Each Wrong Option is Incorrect**
- **Option A:** is incorrect because does have antipseudomonal activity.
- **Option B:** is incorrect because also possesses antipseudomonal activity.
- **Option D:** is incorrect because is known for its antipseudomonal activity.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that when treating infections caused by *Pseudomonas aeruginosa*, especially in a hospital setting or in patients with cystic fibrosis, antibiotics with antipseudomonal activity such as **piperacillin-tazobactam**, **ceftazidime**, **cefepime**, and **meropenem** should be considered.

## **Correct Answer:** .